Enanta Pharmaceuticals Aktie
11,80
EUR
-0,10
EUR
-0,84
%
14,24
USD
-0,16
USD
-1,11
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
| 24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
| 21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG |
Werbung
Werbung